Photo from wikipedia
This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior. Click to show full abstract
This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior.
Keywords:
patients initiating;
management barriers;
barriers patients;
utilization management;
therapy;
quantification utilization
Journal Title: JAMA Network Open
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JAMA Network Open
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!